Middle East Pharmaceutical Industries Company (TADAWUL: 4016)
Saudi Arabia
· Delayed Price · Currency is SAR 135.40
+0.60 (0.45%)
Oct 15, 2024, 10:35 AM AST
Middle East Pharmaceutical Industries Company Revenue
Middle East Pharmaceutical Industries Company had revenue of 101.13M SAR in the quarter ending June 30, 2024, with 8.40% growth. This brings the company's revenue in the last twelve months to 366.87M, up 15.26% year-over-year. In the year 2023, Middle East Pharmaceutical Industries Company had annual revenue of 338.44M with 11.82% growth.
Revenue (ttm)
366.87M
Revenue Growth
+15.26%
P/S Ratio
7.34
Revenue / Employee
675.64K
Employees
543
Market Cap
2.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 338.44M | 35.78M | 11.82% |
| Dec 31, 2022 | 302.66M | 15.44M | 5.38% |
| Dec 31, 2021 | 287.22M | -14.44M | -4.79% |
| Dec 31, 2020 | 301.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition